Detection of antibodies to the feline leukemia Virus (FeLV) transmembrane protein p15E: an alternative approach for serological FeLV detection based on antibodies to p15E.
The aim of this report was to investigate whether the diagnosis of feline leukemia virus (FeLV) infection by serology might be feasible and useful. Among the various viral proteins, the FeLV env-gene product (SU) and the envelope transmembrane protein p15E were considered promising candidates for the serological diagnosis of FeLV infection. Thus, we evaluated p15E and three other FeLV antigens, namely, a recombinant env-gene product, whole FeLV, and a short peptide from the FeLV transmembrane protein, for their potential to detect FeLV infection. To evaluate possible exposure of cats to FeLV, we tested serum and plasma samples from experimentally and naturally infected and vaccinated cats for the presence of antibodies to these antigens by enzyme-linked immunosorbent assays (ELISAs). The serological results were compared with the p27 and proviral real-time PCR results. We found that p15E displayed a diagnostic sensitivity of 95.7% and a specificity of 100% in experimentally infected cats. In naturally infected cats, p15E showed a diagnostic sensitivity of 77.1% and a specificity of 85.6%. Vaccinated cats displayed minimal antibody levels to p15E, suggesting that anti-p15E antibodies indicate infection rather than vaccination. The other antigens turned out to be too unspecific. The lower specificity in cats exposed to FeLV under field conditions may be explained by the fact that some cats become infected and seroconvert in the absence of detectable viral nucleic acids in plasma. We conclude that p15E serology may become a valuable tool for diagnosing FeLV infection; in some cases, it may replace PCR.
Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Eva
E
Boenzli
Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.
Maik
M
Hadorn
Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Sonja
S
Hartnack
Institute for Medical Virology, Swiss National Centre for Retroviruses, University of Zurich, Zurich, Switzerland.
Jon
J
Huder
Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Regina
R
Hofmann-Lehmann
Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland hlutz@vetclinics.uzh.ch.
Hans
H
Lutz
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002371:Cat Diseases / Q000175:diagnosis*; D002415:Cats; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005256:Leukemia Virus, Feline / Q000276:immunology*; D010949:Plasma / Q000276:immunology; D012192:Retroviridae Infections / Q000175:diagnosis / Q000662:veterinary*; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000662:veterinary*; D014759:Viral Envelope Proteins / Q000276:immunology
D000914:Antibodies, Viral; D014759:Viral Envelope Proteins